DK16890A - Antiviral eller antibakteriel forbindelse og frem gangsmaade til anvendelse heraf - Google Patents

Antiviral eller antibakteriel forbindelse og frem gangsmaade til anvendelse heraf Download PDF

Info

Publication number
DK16890A
DK16890A DK016890A DK16890A DK16890A DK 16890 A DK16890 A DK 16890A DK 016890 A DK016890 A DK 016890A DK 16890 A DK16890 A DK 16890A DK 16890 A DK16890 A DK 16890A
Authority
DK
Denmark
Prior art keywords
antiviral
procedure
antibacterial compound
composition
disclosed
Prior art date
Application number
DK016890A
Other languages
English (en)
Other versions
DK16890D0 (da
DK173078B1 (da
Inventor
Witold Kitczka
Original Assignee
Nika Health Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Inc filed Critical Nika Health Products Inc
Publication of DK16890D0 publication Critical patent/DK16890D0/da
Publication of DK16890A publication Critical patent/DK16890A/da
Application granted granted Critical
Publication of DK173078B1 publication Critical patent/DK173078B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK199000168A 1988-05-26 1990-01-22 Anvendelse af en lysozym-dimer og/eller en ribonuclease-dimer til fremstilling af et lægemiddel til behandling af virus- el DK173078B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US17858888A 1988-05-26 1988-05-26
US17858888 1988-05-26
PCT/US1988/001785 WO1989011294A1 (en) 1988-05-26 1988-05-26 Antiviral or antibacterial compound and method of use
US8801785 1988-05-26
OA59731 1990-01-26
OA59731A OA09785A (en) 1988-05-26 1990-01-26 Antiviral or antibacterial compound and method of use

Publications (3)

Publication Number Publication Date
DK16890D0 DK16890D0 (da) 1990-01-22
DK16890A true DK16890A (da) 1990-01-22
DK173078B1 DK173078B1 (da) 1999-12-20

Family

ID=33162813

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199000168A DK173078B1 (da) 1988-05-26 1990-01-22 Anvendelse af en lysozym-dimer og/eller en ribonuclease-dimer til fremstilling af et lægemiddel til behandling af virus- el

Country Status (23)

Country Link
US (3) US5200182A (da)
EP (1) EP0380484B1 (da)
JP (1) JPH0649659B2 (da)
AT (1) ATE93143T1 (da)
AU (1) AU624331B2 (da)
BG (1) BG60544B1 (da)
CA (1) CA1335425C (da)
CS (1) CS277030B6 (da)
DK (1) DK173078B1 (da)
ES (1) ES2011577A6 (da)
FI (1) FI900412A0 (da)
HK (1) HK42394A (da)
HU (1) HU204710B (da)
IL (1) IL90092A (da)
LV (1) LV10054B (da)
MA (1) MA21560A1 (da)
MW (1) MW390A1 (da)
OA (1) OA09785A (da)
PH (1) PH26284A (da)
RU (1) RU2092183C1 (da)
WO (1) WO1989011294A1 (da)
YU (1) YU109289A (da)
ZA (1) ZA893382B (da)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0380484B1 (en) * 1988-05-26 1993-08-18 Nika Health Products Limited Use of a lysozyme dimer and/or a ribonuclease dimer for th emanufacture of an antiviral or antibiotic drug
ES2086403T3 (es) * 1990-01-08 1996-07-01 Nika Health Products Ltd Procedimiento para la elaboracion de dimeros de ribonucleasa.
US5989880A (en) * 1990-01-08 1999-11-23 Nika Health Products Ltd. Method of preparing lysozyme dimers
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
CH682541A5 (de) * 1992-06-23 1993-10-15 Urs Viktor Dr Wirth Biochemische Inaktivierung von RNA-Viren.
US6183742B1 (en) 1992-07-13 2001-02-06 Nika Health Products, Limited Applications of lysozyme dimer
DZ1964A1 (fr) * 1995-01-13 2002-10-15 Nika Health Products Ltd Nouvelle applications d'un dimère de lysozyme.
GB2304048A (en) * 1995-08-12 1997-03-12 John William Carson Medicament containing saliva extract
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
US7338936B2 (en) * 2000-11-28 2008-03-04 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
US6716813B2 (en) * 2000-11-28 2004-04-06 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
JP2002187853A (ja) * 2000-12-21 2002-07-05 Shinei Ferumentekku:Kk 動物の乳頭除菌剤および菌環境改善方法
DE10210285A1 (de) * 2002-03-08 2003-11-13 Medigene Ag Reversibles Toxin und seine Verwendung
US8470315B2 (en) 2004-04-13 2013-06-25 Quintessence Biosciences, Inc. Non-natural ribonuclease conjugates as cytotoxic agents
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
US7348301B2 (en) * 2006-02-16 2008-03-25 Buckman Laboratories International, Inc. Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems
US8840882B2 (en) * 2006-06-23 2014-09-23 Quintessence Biosciences, Inc. Modified ribonucleases
US8298801B2 (en) 2006-07-17 2012-10-30 Quintessence Biosciences, Inc. Methods and compositions for the treatment of cancer
EP2134354A4 (en) * 2007-03-02 2012-03-21 Saint Simeon Lda COMPOSITION AND METHOD FOR THE TREATMENT OF PAPILLOMA VIRUS AND HORSE SARCODES
WO2009036000A2 (en) * 2007-09-11 2009-03-19 University Of Maryland, Baltimore Methods of treating a microbial infection by modulating rnase-l expression and/or activity
EP2205271B1 (en) * 2007-10-08 2014-05-21 Quintessence Biosciences, Inc. Compositions and methods for ribonuclease-based therapies
EP2334695B1 (en) 2008-10-01 2015-12-23 Quintessence Biosciences, Inc. Therapeutic ribonucleases
US20100215707A1 (en) * 2009-02-25 2010-08-26 Mcdonald Thomas Activated creatinine and precursors thereof as antibacterial agents, compositions and products containing such agents and uses thereof
NZ600269A (en) 2009-05-20 2014-02-28 Dec Int Nz Ltd Delivery device for treatment of mastitis
PL2457576T3 (pl) 2010-11-29 2021-04-06 Eurochit Danuta Kruszewska Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji
RU2548803C2 (ru) * 2011-11-28 2015-04-20 Общество с ограниченной ответственностью " Фарматренд" ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ ГЛАЗНЫХ ИНФЕКЦИЙ P. Aeruginosa, СОДЕРЖАЩАЯ РЕКОМБИНАНТНЫЙ ЛИЗОЦИМ
RU2509801C2 (ru) * 2012-03-22 2014-03-20 Борис Михайлович Куриненко СПОСОБ ИСПОЛЬЗОВАНИЯ РИБОНУКЛЕАЗЫ Bacillus intermedius
CN104684565A (zh) 2012-05-29 2015-06-03 达努塔·克鲁谢夫斯卡 在人类和兽医的预防和医疗中有用的、包含罗伊氏乳杆菌dan080的纳米产品及其医疗用途
EP2674162A1 (en) 2012-05-29 2013-12-18 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
RU2504397C1 (ru) * 2012-10-25 2014-01-20 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая фермент рибонуклеазу и глицирризиновую кислоту или ее соли: глицирризинат аммония, или дикалия, или тринатрия
WO2014152678A1 (en) 2013-03-15 2014-09-25 University Of Massachusetts Compositions and methods for delivering agents to the central nervous system
US9573980B2 (en) 2013-03-15 2017-02-21 Spogen Biotech Inc. Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots
EP3108894B1 (en) 2014-02-21 2022-01-26 Kewpie Corporation Non-therapeutic method of deactivating norovirus, use of lysozyme component for non-therapeutic norovirus deactivation, and lysozyme component for use in the prevention or treatment of norovirus infection
KR20170038829A (ko) * 2014-07-31 2017-04-07 큐피가부시키가이샤 함수 유동상 조성물 및 그 제조 방법, 그리고 리소자임 가공품 및/또는 그 염 그리고 그 제조 방법
BR122023020829A2 (pt) 2014-09-17 2024-01-23 Spogen Biotech Inc. Bactéria recombinante formadora de esporos, sua formulação, e semente de planta revestida com as mesmas
LV15071B (lv) * 2015-07-14 2016-02-20 Rīgas Stradiņa Universitāte Kompozīcija subklīniska mastīta ārstēšanai govīm
RU2634264C1 (ru) * 2016-09-19 2017-10-24 Александр Ливиевич Ураков Крем-молочко для лечения опоясывающего лишая
KR102470362B1 (ko) 2016-12-28 2022-11-25 디아이씨 가부시끼가이샤 분산체 및 그것을 사용한 잉크젯용 잉크 조성물, 광변환층, 및 액정 표시 소자
WO2021021765A1 (en) * 2019-07-26 2021-02-04 Evolve Biosystems, Inc. Nutritive compositions with bioactive proteins

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1268M (fr) * 1961-06-29 1962-04-24 Puiseux Médicament antimitotique et antiviral.
FR4020M (da) * 1965-01-29 1966-03-21
DE1517751C3 (de) * 1965-07-08 1975-02-27 Eisai Co., Ltd., Tokio Verfahren zum Verhindern der Bildung von flockigen Lysozym- und/oder Lysozymsalzniederschlägen in wässrigen Lösungen, die Lysozym und/oder Lysozymsalze enthalten
DE1545644A1 (de) * 1965-12-06 1969-08-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen quaternaeren Scopolammoniumsalzen
GB1110504A (en) * 1966-03-18 1968-04-18 Prodotti Antibiotici Spa Pharmaceutical compositions
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
US4510144A (en) * 1981-08-26 1985-04-09 Newport Pharmaceuticals International Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
CA1263378A (en) * 1985-01-08 1989-11-28 Robert James Alaimo Imidazo¬4,5-f|quinolines useful as immunomodulating agents
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
EP0380484B1 (en) * 1988-05-26 1993-08-18 Nika Health Products Limited Use of a lysozyme dimer and/or a ribonuclease dimer for th emanufacture of an antiviral or antibiotic drug

Also Published As

Publication number Publication date
BG60544B1 (en) 1995-08-28
MA21560A1 (fr) 1989-12-31
ZA893382B (en) 1991-01-30
HU883981D0 (en) 1990-12-28
DK16890D0 (da) 1990-01-22
CS277030B6 (en) 1992-11-18
YU109289A (en) 1991-08-31
OA09785A (en) 1994-04-15
IL90092A (en) 1995-03-30
HU204710B (en) 1992-02-28
ES2011577A6 (es) 1990-01-16
AU624331B2 (en) 1992-06-11
AU1940888A (en) 1989-12-12
US6099835A (en) 2000-08-08
LV10054B (en) 1995-02-20
EP0380484A1 (en) 1990-08-08
LV10054A (lv) 1994-05-10
MW390A1 (en) 1990-11-14
WO1989011294A1 (en) 1989-11-30
JPH0649659B2 (ja) 1994-06-29
ATE93143T1 (de) 1993-09-15
US5466449A (en) 1995-11-14
CA1335425C (en) 1995-05-02
FI900412A0 (fi) 1990-01-25
DK173078B1 (da) 1999-12-20
PH26284A (en) 1992-04-10
RU2092183C1 (ru) 1997-10-10
HK42394A (en) 1994-05-13
CS318089A3 (en) 1992-05-13
US5200182A (en) 1993-04-06
EP0380484B1 (en) 1993-08-18
HUT54060A (en) 1991-01-28
JPH03504121A (ja) 1991-09-12

Similar Documents

Publication Publication Date Title
DK16890D0 (da) Antiviral eller antibakteriel forbindelse og frem gangsmaade til anvendelse heraf
KR950700333A (ko) 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes)
IT1232827B (it) Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
ATE42309T1 (de) Knockenbildungsfaktoren.
NO169900C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (ih-azol-1-ylmetyl)substituerte benzotriazolderivater
PT1019040E (pt) Inibicao da actividade de p38-quinase por meio de arilureias
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
EE9900428A (et) Köhavastased ravimkoostised
NO884456L (no) Fremgangsmaate til minskning av vandring av metallprodukter i elektroder.
FI940375A (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
BR9607541A (pt) Tratamento de doenças que tem por causa o fator de crescimento da citoquina
PH27214A (en) N-2,3-butadienyl tri and tetraaminoalkane derivatives
LTIP610A (en) Inhibitors of cells proliferation, pharmaceutical composition and method for preparation of compounds
NO931413D0 (no) Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer
AU2840889A (en) Method of treating haematologic diseases and pharmaceutical compositions to be used therefor
DE69816808D1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
IE870577L (en) Topical amide preparation
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
MY106984A (en) Antiviral or antibacterial composition and method of use.
IT8348383A0 (it) Enzima simile a pepsina da leucocito umano, procedimento per prepararlo, e composizione terapeutica che lo contiene come ingrediente attivo
GR1001006B (el) Μεθοδος παρασκευης και χρησιμοποιησεως αντιιικων η αντιβακτηριακων συνθεσεων.
GEP19971029B (en) Antiviral or antibacterial compound and method of use thereof
AU2314488A (en) Anthelmintic acylhydrazones, method of use and compositions
SE9003140D0 (sv) Method and composition for treatment of heart diseases

Legal Events

Date Code Title Description
PUP Patent expired